Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

chugai_pharmaceutical

Chugai partners with Osaka University in £62 million immunology collaboration

May 20, 2016 Medical Communications, Research and Development Chugai, collaboration, immunology, osaka university

Chugai Pharmaceuticals (TOKYO: 4519) has announced a collaboration agreement with Osaka University in advanced immunology research worth up to £62 …
News
clinical_trial_3

Celator receives FDA breakthrough therapy designation for leukaemia drug

May 20, 2016 Medical Communications, Research and Development FDA, Vyxeos, acute myeloid leukaemia, breakthrough therapy, celator

A new treatment for acute myeloid leukaemia and other blood cancers from Celator Pharmaceuticals (NASDAQ: CPXX) has been granted breakthrough …
News

Urgent action needed on antimicrobial resistance, says government report

May 19, 2016 Manufacturing and Production, Medical Communications, Research and Development ABPI, Lord Jim O'Neill, NICE, antimicrobial resistance

A new UK governmental report has warned that the global rise of antimicrobial resistance is set to worsen, with the …
News
michael_becker

Relmada Therapeutics appoints new chief financial officer

May 17, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing chief financial officer, relmada

Michael D. Becker has been appointed the new chief financial officer at Relmada Therapeutics. Becker joined the company in 2014 …
Appointment
doc_writing

US pass new laws to combat opioid epidemic

May 13, 2016 Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse

The US has passed new laws that will seek to combat the current epidemic of opioids across the country. The …
News
lab

EU approves Idelvion for haemophilia B treatment

May 13, 2016 Medical Communications, Research and Development CSL, EU, Idelvion, approval, haemophilia B

The European Commission has approved Idelvion, coagulation Factor IX (recombinant) for the treatment and prophylaxis of bleeding in patients with …
News
sanofi_pasteur_scientist

Sanofi Files Hart-Scott-Rodino notification for Medivation acquisition

May 13, 2016 Medical Communications, Sales and Marketing M&A, MA, Medivation, Sanofi, deal

French drugmaker Sanofi (Euronext: SAN) on Friday said it has filed a premerger notification with the US Department of Justice Antitrust …
News
biogen_logo

Sobi, Biogen’s haemophilia B therapy gets European approval

May 13, 2016 Medical Communications, Research and Development, Sales and Marketing Biogen, haemophilia B, orphan designation, regulation, sobi

Sobi (STO: SOBI) and Biogen (Nasdaq: BIIB) on Friday said the European Commission has approved their drug to treat haemophilia B. The …
News

Bayer terminates clinical trial for hypertension due to safety concerns

May 13, 2016 Medical Communications, Research and Development Bayer, clinical trial, deaths, pulmonary hypertension, riociguat, safety concerns

Bayer has terminated a Phase II trial evaluating riociguat in patients with pulmonary hypertension due to fears raised by an …
News
james_kehoe

Takeda appoints new chief financial officer

May 12, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe

Takeda Pharmaceuticals has named James Kehoe its new chief financial officer. He will begin the role on June 15 2016, …
Appointment

BMS says Nice refuses backing for its immunotherapy Opdivo to treat lung cancer

May 12, 2016 Medical Communications, Research and Development, Sales and Marketing

The National Institute for Health and Care Excellence (Nice) has rejected US pharma firm Bristol-Myers Squibb’s (NYSE: BMY) immune-oncology drug …
News
lilly_entrance_web

FDA issues warning about rare, but serious, side effect in Lilly antipsychotic drug

May 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, FDA, anti-psychotic, boxed warning, lilly, olanzapine, skin condition

The US Food and Drug Administration (FDA) has issued a new warning to all drug labels for Eli Lilly’s antipsychotic …
News

Nice recommends two blood tests to rule out pre-eclampsia in pregnant women

May 11, 2016 Medical Communications, Sales and Marketing NICE, Roche, regulation

The National Institute for Health and Care Excellence (Nice) has backed two blood tests to help rule-out a complication in …
News
abpi_reception_right

UK pharma would benefit by remaining in EU, says ABPI

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay

With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …
News
shutterstock_67313209

Focus: Governments evaluate policies, reforms as drug pricing debate rages on

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

By Anjali Shukla Lawmakers in France are set to urge the leaders of G7 countries to put in place guidelines …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025